Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-09-11
2007-09-11
Davis, Zinna N. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S252100, C514S256000, C514S307000, C514S310000, C514S311000, C514S313000, C514S352000, C514S357000, C514S367000, C514S370000, C514S374000, C514S375000, C514S406000, C514S407000, C514S562000, C544S224000, C544S242000, C544S336000, C546S147000, C546S152000, C546S304000, C546S341000, C548S148000, C548S216000, C562S430000
Reexamination Certificate
active
11000711
ABSTRACT:
The present invention relates to biaryl sulfonamides and their use as, for example, metalloproteinase inhibitors.
REFERENCES:
patent: 0 950 656 (1999-10-01), None
patent: 97/44315 (1997-11-01), None
patent: 00/51993 (2000-09-01), None
patent: 00/51993 (2000-09-01), None
patent: 01/27084 (2001-04-01), None
U.S. Appl. No. 11/001,589, filed Dec. 1, 2004, Levin et al.
Tamura, Y. et al., “Highly Selective and Orally Active Inhibitors of Type IV Collagenase (MMP-9 and MMP-2):N-Sulfonylamino Acid Derivatives,”J Med Chem, 1998, 41:640-649.
Tang, B. L., “ADAMTS: a novel family of extracellular matrix proteases,”,Int J Biochem Cell Biol, 2001, 33:33-44.
Abbaszade I. et al., “Cloning and Characterization of ADAMTS11, an Aggrecanase from the ADAMTS family,”J Biol Chem, Aug. 13, 1999, 274(33): 23443-23450.
Colige, A. et al., “cDNA cloning and expression of bovine procollagen I N-proteinase: A new member of the superfamily of zinc-metalloproteinases with binding sites for cells and other matrix components,”Proc Natl Acad Sci USA, Mar. 1997, 94, 2374-2379.
Vázquez F. et al., “METH-1, a Human Orgholog of ADAMTS-1, and METH-2 Are Members of a New Family of Proteins with Angio-inhibitory Activity,”J Biol Chem, Aug. 13, 1999, 274(33): 23349-23357.
Masui T., et al., “An Alu-linked Repetitive Sequence Corresponding to 280 Amino Acids Is Expressed in a Novel Bovine Protein, but Not in Its Human Homologue,”J Biol Chem, Jan. 31, 1997, 272(5), 2801-2807.
Kuno, K. et al., “Molecular Cloning of a Gene Encoding a New Type of Metalloproteinase-disintegrin Family Protein with Thrombospondin Motifs as an Inflammation Associated Gene,”J Biol Chem, Jan. 3, 1997, 272(1), 556-562.
Bundgaard, H. (ed.),Design of Prodrugs, Elsevier (1985), Ch. 1 (pp. 1-92), Ch. 4 (pp. 157-176), Ch. 5 (pp. 177-198), and Ch. 6 (pp. 199-241).
Widder, et al. (ed.),Methods in Enzymology, vol. 112, Academic Press (1985), pp. 309-396.
Krogsgaard-Larsen, et al., (ed).Design and Application of Prodrugs, Textbook of Drug Design and Development, Chapter 5, 113-191, 1991.
Bundgaard, H., “Means to enhance penetration; Prodrugs as a means to improve the delivery of peptide drugs,”Advanced Drug Deliver Reviews, 1992, 8, 1-38.
Bundgaard, H. et al., “Glycolamide Esters as Biolabile Prodrugs of Carboxylic Acid Agents: Synthesis, Stability, Bioconversion, and Physicochemical Properties,”J. of Pharmaceutical Sciences, Apr. 1988, 77(4):285-298.
Higuchi and Stella (eds.),Prodrugs as Novel Drug Delivery Systems, American Chemical Society (1975), pp. 1-115 and 196-223.
Laemmli, U. K., “Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4,”Nature, Aug. 15, 1970, 227:680-685.
Oaklet, B. R. et al., “A Simplified Ultrasensitive Silver Stain for Detecting Proteins in Polyacrylamide Gels,”Anal. Biochem, 1980, 105:361-363.
Towbin, H. et al., “Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications,”Proc. Natl. Acad. Sci. USA, Sep. 1979, 76(9), 4350-4354.
Hughes, C. E. et al., “Monoclonal antibodies that specifically recognize neoepitope sequences generated by ‘aggrecanase’ and matrix metalloproteinase cleavage of aggrecan: application to catabolism in situ and in vitro,”Biochem J, Feb. 1, 1995, 305(3), 799-804.
Romero, D. L. et al, “Discovery, Synthesis, and Bioactivity of Bis(heteroaryl)piperazines. 1. A Novel Class of Non-Nucleoside HIV-1 Reverse Tranascriptase Inhibitors,”J. Med. Chem. 1994, 37, 999-1014.
Emmott, P. et al., “Preparation of Some Naphthofurans,”J. Chem. Soc. (Jul. 1957) pp. 3144-3148.
Evans, D. A. et al., “Synthesis of Diaryl Ethers through the Copper-Promoted Arylation of Phenols with Arylboronic Acids. An Expedient Synthesis of Thyroxine,”Tetrahedron Lett., May 7, 1998, 39(19):2937-2940.
Bencze, W. L. et. al, “The Absolute Configuration of a Hypolipidemic 1-Aryl Tetralin, Nafenopin,”Tetrahedron1970, 26:5407-5414.
Werner, A. W. et al., “Porphyrins with Four Azole Substituents in meso Positions: X-Ray Crystal Structure of Meso-tetrakis-(1-benzylpyrazol-4-yl)-porphyrin at 200 K,”Tetrahedron, Apr. 17, 1995, 51(16): 4779-4800.
Burtner, R.R. et al., “Antispasmodics. I. Basic Esters of Some Arylacetic Acids,”J. Am. Chem. Soc., 1943, 65:262-267.
Abramov, M. A. et al., “Nucleophilic Intramolecular Cyclization Reactions of Alkylnechalcogenolates,”Tetrahedron, Jun. 9, 2000, 56(24): 3933-3940.
Knight, C.G. et al., “A novel-coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases,”FEBS Lett. (Jan. 1992) 296(3):263-266.
Remington's Pharmaceutical Sciences, 17thEd., Gennaro, A. R. (Ed.), Mack Publishing Company, Easton, PA (1985) pp. 1409-1677.
Hopper Darrin William
How David Brian
Hu Yonghan
Rush, III Thomas Saltmarsh
Sabatini Joshua James
Davis Zinna N.
Woodcock & Washburn LLP
Wyeth
LandOfFree
Biaryl sulfonamides and methods for using same does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biaryl sulfonamides and methods for using same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biaryl sulfonamides and methods for using same will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3737839